Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-12-15

FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for risperidone from ANI Pharmaceuticals, Inc., resulting in a generic risperidone product being approved. Risperido…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)